Logo

American Heart Association

  21
  0


Final ID: MP1230

Variation in Impella 5.5 Support Duration and Ischemic Time Across Donor Transport Technologies

Abstract Body (Do not enter title and authors here): Background: Mechanical support strategies used for patients in shock prior to heart transplantation (OHT) correlates with post-transplant outcomes. OHT timing in patients supported by Impella 5.5 remains an evolving decision point, influenced by patient stability and donor logistics. With the emergence of organ transport technologies, we sought to determine whether the choice of system was associated with variations in pre-transplant support duration.
Method: A retrospective review between Jan 2020 and May 2025 was completed. Patients were categorized by donor transport technology: traditional cooler, Organ Care System (OCS), or SherpaPak. The primary outcome was duration of Impella support (days) prior to transplant. Group-wise comparisons were performed using Kruskal-Wallis testing.
Result: A total of 129 patients were assessed across three transport methods: traditional cooler:12, OCS: 35, SherpaPak: 84. Median age at transplant was 58 (51-65) years with EF of 17% (15-22). Cold ischemic time differed significantly across transport technologies (Kruskal-Wallis H = 77.4, p < 0.001) and was longest in OCS cases (417 min), compared to SherpaPak (236 min) and traditional cooler (234 min). The median duration of Impella support prior to OHT was 27 days for organs transported via traditional cooler, 25 days for those using OCS, and 28.5 days for SherpaPak with near-significant difference by transport method (H=5.77, p=0.056). There was no significant difference of rejection within the first year after OHT.
Conclusion: Donor transport technology choice may serve as a surrogate for broader transplant logistics and selection strategies as evidenced by significant differences in ischemic time and near-significant trends in Impella support duration.
  • Dadwal, Surbhi  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Desai, Aarti  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Ruiz, Jose  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Shapiro, Anna  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Goswami, Rohan  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Author Disclosures:
    Surbhi Dadwal: DO NOT have relevant financial relationships | Aarti Desai: DO NOT have relevant financial relationships | Jose Ruiz: DO NOT have relevant financial relationships | Anna Shapiro: No Answer | Rohan Goswami: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Pushing the Limits: ECMO, Impella, and the Science Behind Their Power

Sunday, 11/09/2025 , 09:15AM - 10:15AM

Moderated Digital Poster Session

More abstracts on this topic:
A Culturally Tailored mHealth Lifestyle Intervention Improves Diet and Physical Activity Self-Regulation Among African Americans

Lalika Mathias, Jenkins Sarah, Hayes Sharonne, Jones Clarence, Burke Lora, Cooper Lisa, Patten Christi, Brewer Laprincess

3-Minute Heart Health App: A Feasibility Study

Abdulkarim Iya, Metzger Joseph, Stovitz Steven, Van't Hof Jeremy

More abstracts from these authors:
Donor Heart Transport Technology as a Determinant of Survival in Contemporary Heart Transplantation

Dadwal Surbhi, Desai Aarti, Ruiz Jose, Shapiro Anna, Martin Archer, Haney John, Goswami Rohan

Support duration as a prognostic indicator in temporary MCS: divergent outcomes based on the 14-day FDA approved duration

Desai Aarti, Patel Parag, Goswami Rohan, Mautong Hans, Dadwal Surbhi, Wlodkowski Peter, Ruiz Jose, Yip Daniel, Lyle Melissa, Leoni Juan, Nativi-nicolau Jose

You have to be authorized to contact abstract author. Please, Login
Not Available